Tirzepatide represents a groundbreaking treatment agent for individuals facing type 2 diabetes. As a dual receptor activator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic https://larissazhzi956696.blog-eye.com/40915876/tirzepatide-a-new-frontier-in-diabetes-treatment